Showing results (4091-4100 of 9,444) with videos related to
Sort By:
Pageof 945
Clinical Endocrinology|March 20, 2013
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levelsAlessandro Ciresi, Marco Calogero Amato, Valentina Guarnotta, et al.Clinical Endocrinology|March 20, 2013
Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomasMaría Celia Fernandez, Ayelen Martin, Marcela Venara, et al.Clinical Endocrinology|March 21, 2013
Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older menBu B Yeap, Helman Alfonso, S A Paul Chubb, et al.Clinical Endocrinology|April 12, 2013
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonistsTrevor A Howlett, Debbie Willis, Gillian Walker, et al.Clinical Endocrinology|May 14, 2013
Developing long-acting growth hormone formulationsPippa Cawley, Ian Wilkinson, Richard J RossClinical Endocrinology|June 11, 2013
The relationship between bone mass and body composition in children with hypothalamic and simple obesityM Guftar Shaikh, Nicola Crabtree, Jeremy M W Kirk, et al.Clinical Endocrinology|June 11, 2013
Metabolic syndrome is strictly associated with parental obesity beginning from childhoodAlice Monzani, Anna Rapa, Nicola Fuiano, et al.Clinical Endocrinology|January 26, 2013
Screening for X-linked adrenoleukodystrophy among adult men with Addison's diseaseMorten A Horn, Martina M Erichsen, Anette S B Wolff, et al.Clinical Endocrinology|January 26, 2013
A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinomaAshu Rastogi, Anil Bhansali, Pinaki Dutta, et al.Clinical Endocrinology|April 19, 2012
GH levels and insulin sensitivity are differently associated with biomarkers of cardiovascular disease in active acromegalyL Boero, M Manavela, T Meroño, et al.Pageof 945